Imaging the spread of reversible brain inactivations using fluorescent muscimol
Introduction
Reversible inactivations of small volumes of brain tissue have been used to explore fundamental questions in behavioral and systems neuroscience (Majchrzak and Di Scala, 2000). Reversible inactivations are an important alternative to permanent brain lesions (Jarrard, 2002) in assessing structure–function relationships. The obvious advantage is that reversible brain inactivations allow within-subject designs. One common disadvantage is that this method typically leaves considerable uncertainty about the size and shape of the volume of the drug-infused tissue.
Muscimol, a GABAA-agonist (Beaumont et al., 1978), is commonly and productively used for reversible inactivations (Krupa and Thompson, 1997, Lomber, 1999, Martin and Ghez, 1999). However, the spatial extent of a muscimol infusion is indeterminate without the use a radioactive tracer ([3H]muscimol; Edeline et al., 2002, Martin, 1991). Indirect estimates about the spread of muscimol have been obtained by measuring its anticipated functional consequences on glucose uptake (Martin, 1991), evoked field potentials (Wilensky et al., 2006), and multiunit activity levels (Arikan et al., 2002, Edeline et al., 2002). Practical considerations have precluded the routine use of either radioactive or functional techniques (but see Krupa and Thompson, 1997).
Here we evaluated the use of a fluorophore-conjugated muscimol molecule (FCM) for producing local and reversible brain inactivations. FCM was first used in conjunction with muscimol to assess the role of dorsomedial prefrontal cortex (dmPFC) in a delayed-response task (Narayanan and Laubach, 2006, Narayanan et al., 2006). Our evaluation of FCM made use of whole-cell recordings, well-characterized brain–behavior relationships, and optical quantification methods. The results show that FCM can serve as a stand-alone and practical substitute for muscimol.
Section snippets
Subjects
This study used a total of 15 rats, described for each experiment below. Procedures were approved by the Yale University Animal Care and Use Committees (whole-cell, acute infusion, and fear conditioning) and the John B. Pierce Laboratory (delayed-response task).
Drugs
Muscimol was acquired from Sigma–Aldrich. FCM (commercially designated as muscimol, BODIPY® TMR-X conjugate) was acquired from Molecular Probes (product #M23400, www.molecularprobes.com). FCM is a conjugate of muscimol and the Bodipy®
Effects of FCM on excitatory postsynaptic potentials and input resistance
Horizontal rat brain slices were used to verify that FCM, like unlabeled muscimol, does in fact suppress neuronal and synaptic function. Whole-cell recordings were made from neurons in layer V of PR. Synaptic responses were evoked in these neurons by stimulating layer I of PR. The complete experimental protocol was conducted on 11 healthy cells recorded from 3 rat pups. In each case, bath application FCM (10 μM in aCSF) caused an immediate and rapid suppression of excitatory synaptic
FCM reversibly depresses synaptic transmission
Whole-cell recordings in PR showed that bath application of FCM decreased the mean amplitude of EPSPs and also decreased RN (Fig. 2). These results show that the desired neuropharmacological action persists after conjugating muscimol with a large fluorophore. Following washout of FCM from the bath, the recovery of neural function required hours (Fig. 2). The slow reversal may result from the lipophilic properties of the Bodipy-TMR-X fluorophore®, as discussed below.
FCM spread is not always uniform
The spread of FCM can be
Acknowledgements
This work was supported by a National Institute of Health grant (MH58405) and Yale University to Thomas H. Brown; supported by a National Science Foundation grant (0642951) and the Kavli foundation awarded to Mark Laubach.
References (31)
- et al.
Single-unit responses to 22 kHz ultrasonic vocalizations in rat perirhinal cortex
Behav Brain Res
(2007) - et al.
A method to measure the effective spread of focally injected muscimol into the central nervous system with electrophysiology and light microscopy
J Neurosci Methods
(2002) - et al.
Muscimol binding in rat brain: association with synaptic GABA receptors
Brain Res
(1978) Ultrasonic calls of rats as indicator variables of negative or positive states. Acetylcholine–dopamine interaction and acoustic coding
Behav Brain Res
(2007)- et al.
Muscimol diffusion after intracerebral microinjections: a reevaluation based on electrophysiological and autoradiographic quantifications
Neurobiol Learn Memory
(2002) The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function
J Neurosci Methods
(1999)Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat
Neurosci Lett
(1991)- et al.
Pharmacological inactivation in the analysis of the central control of movement
J Neurosci Methods
(1999) - et al.
Methods for whole-cell recording from visually preselected neurons of perirhinal cortex in brain slices from young and aging rats
J Neurosci Methods
(1998) - et al.
Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex
Neuron
(2006)
Reversible inactivations of rat medial prefrontal cortex impair the ability to wait for a stimulus
Neuroscience
The production of ultrasonic sounds by laboratory rats and other mammals
Science
Crouching as an index of fear
J Comp Physiol Psychol
Statistical power analysis for the behavioral sciences
Morphology and physiology of neurons in the rat perirhinal-lateral amygdala area
J Comp Neurol
Cited by (163)
Sequential order spatial memory in male rats: Characteristics and impact of medial prefrontal cortex and hippocampus disruption
2023, Neurobiology of Learning and MemoryPrioritization of social information by the basolateral amygdala in rats
2021, Neurobiology of Learning and Memory